Diselenide-Based Dual-Responsive Prodrug as Pyroptosis Inducer Potentiates Cancer Immunotherapy.
Wan SC, Ye MJ, Yang QC, Zhang T, Zhang MJ, Ma XB, Xu JM, Wang S, Wu ZZ, Yang LL, Shen XM, Xu Z, Sun ZJ.
Wan SC, et al. Among authors: shen xm.
Adv Healthc Mater. 2023 Mar;12(7):e2202135. doi: 10.1002/adhm.202202135. Epub 2022 Dec 11.
Adv Healthc Mater. 2023.
PMID: 36479643